Global proton therapy market projected to reach $2,405.6 million by 2032 with growth driven by cancer incidence.

From GlobeNewswire:

The Proton Therapy Market is projected to reach $2,405.6 million by 2032, with a CAGR of 12.11%. The primary driver of growth is the increasing incidence of cancer worldwide. Technological advancements in proton therapy systems are enhancing treatment precision and reducing side effects. Challenges include high treatment costs and limited availability of treatment centers.

North America leads the global proton therapy market, with Asia Pacific emerging as the fastest-growing region. Asia Pacific’s rapid expansion is driven by a surge in cancer cases, investments in healthcare infrastructure, and technological advancements. Countries like China, Japan, South Korea, and India are actively investing in upgrading their healthcare systems to make proton therapy more accessible. Technological innovations and government support further contribute to growth in the region.



Read more at GlobeNewswire: [Latest] Global Proton Therapy Market Size/Share Worth USD